latest tirzepatide news Medscape Obesity drug seen as effective
Description
Semaglutide injection placement matters for consistent absorption and comfort
Yale School of Medicine
Initially approved to treat diabetes, glucagon-like peptide-1 (GLP-1) drugs are being heralded to address obesity and, more recently, obstructive sleep apnea (OSA).
Modern biology (INP 2.0 view) GLP-1 is secreted by intestinal L-cells and regulates insulin secretion, glucagon suppression, gastric emptying, satiety, -cell survival, gutbrain signaling, and inflammation
Tirzepatide injections work best when administered on the same day each week
